<DOC>
	<DOCNO>NCT02279329</DOCNO>
	<brief_summary>Subjects male female age 50-85 clinical diagnosis chronic obstructive pulmonary disease ( COPD ) Bronchiectasis , ≥ 10 pack/years smoke history image CT MRI development tool quantify validate longitudinal vivo magnetic resonance image phenotype COPD Bronchiectasis .</brief_summary>
	<brief_title>Longitudinal Study Helium-3 Xenon-129 Magnetic Resonance Imaging</brief_title>
	<detailed_description>COPD patient stratify four group : Gold Stage 0 , Gold Stage I , Gold Stage II , Gold Stage III . During single 2-2 ½ hour visit , patient subject perform : 1 ) spirometry pre-and-post salbutamol plethysmography , Lung Clearance Index , Airway Oscillometry ( Airwave Oscillometry measure mechanic respiratory system superimpose gentle multi-frequency airwave onto patient 's respiratory airflow . Measurements take long 16 second patient simply breathes normally disposable mouthpiece duration test . ) 2 ) 6MWT ( include Borg questionnaire pre-and post-walk ) , 3 ) health status evaluation use self-administered SGRQ MMRC ( Modified Medical Research Council dyspnea scale ) 4 ) CT , , 5 ) 3He MRI . Subjects first provide write informed consent screen MRI compatibility complete : 1 ) Spirometry pre-salbutamol , SGRQ inhale 2-4 puff ( 200-400μg ) short-acting bronchodilator ( eg . Salbutamol ) , 2 ) MRI , 3 ) CT. ( Subjects take wheelchair University Hospital , LHSC decrease potential dynamic hyperinflation ) , 4 ) plethysmography spirometry within 1 ½ hour salbutamol . Vital sign perform . Because impossible schedule image time-point post-bronchodilator , subject randomize MR CT 30 minute post-salbutamol ( 1:1 ratio ) , minimize bias .</detailed_description>
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Subjects male female age 5085 either A ) clinical diagnosis COPD Bronchiectais B ) &gt; 10 pack/year smoke history Subject understand study procedure willing participate study indicate signature inform consent Subject must able perform breathhold 16 . Subject judged otherwise stable health basis medical history Subject ambulatory perform 6MWT Subject able perform reproducible pulmonary function test ( i.e. , 3 best acceptable spirogram FEV1 value vary 5 % large value 100 ml , whichever great . ) FEV1 &gt; 25 % predict FVC &gt; 25 % predict &gt; 0.5L Patient , opinion investigator , mentally legally incapacitate , prevent informed consent obtain , read understand write material . Subject daytime room air oxygen saturation &lt; 90 % lie supine . Patient unable perform spirometry plethysmography maneuver Patient pregnant In investigator 's opinion , subject suffers physical , psychological condition ( ) might prevent performance MRI , severe claustrophobia . Subject implant mechanically , electrically magnetically activated device metal body remove , include limited pacemaker , neurostimulators , biostimulators , implanted insulin pump , aneurysm clip , bioprosthesis , artificial limb , metallic fragment foreign body , shunt , surgical staple ( include clip metallic suture and/or ear implant . )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>